U.S. Leads Shift Toward Minimally Invasive Uterine Fibroid Treatments

toegevoegd een audio Health

2025-06-16 10:51:24

The uterine fibroids treatment market is on a robust growth trajectory, expected to expand from USD 5.5 billion in 2024 to over USD 8.5 billion by 2031, at a CAGR of 6.5%. Rising awareness of women’s reproductive health, minimally invasive surgery options, hormone-free therapies, and global access to advanced diagnostics are fueling this demand. With nearly 70–80% of women affected...

0 Reacties 0 aandelen 114 Views 0 voorbeeld